Oral health strategies like screening, education, and medical-dental collaboration can improve cardiovascular care by reducing shared risk factors and inflammation.
Read the full answer →
Yes, processed meat increases cancer risk for everyone, including people with cardiovascular diseases, due to shared risk factors and inflammatory pathways.
Read the full answer →
Higher Lp(a) levels are linked to more severe coronary artery disease, with a stepwise increase in Lp(a) as the number of blocked vessels rises.
Read the full answer →
Yes, liver biomarkers like GGT, ALP, and globulin can improve 10-year ASCVD risk prediction in both US and Chinese populations, especially when added to traditional risk factors.
Read the full answer →
Common lipid-lowering treatments for ASCVD patients with FH in Israel include high-intensity statins, ezetimibe, and PCSK9 inhibitors, though real-world data show many patients still have uncontrolled LDL-C.
Read the full answer →
Extracellular vesicles (EVs) can both promote and inhibit vascular calcification in cardiovascular disease, depending on their cargo and cellular origin.
Read the full answer →
Chronic air pollution worsens heart conditions in children and older adults by triggering inflammation, oxidative stress, and vascular damage, with older adults facing higher cardiovascular mortality and children experiencing long-term developmental risks.
Read the full answer →
Risk calculators like Heart Age, along with LDL-C and blood pressure numbers, help patients with CVD understand their personal risk. Tools that show 'heart age' can motivate risk reduction.
Read the full answer →
Yes, potassium salt substitutes lower blood pressure and reduce cardiovascular death risk, based on multiple reviews and trials.
Read the full answer →